Destination Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2M | Buy |
39,993
+2,549
| +7% | +$1.03M | 0.48% | 64 |
|
|
2025
Q1 | $18.6M | Buy |
37,444
+1,719
| +5% | +$855K | 0.59% | 63 |
|
|
2024
Q4 | $18.6M | Buy |
35,725
+361
| +1% | +$188K | 0.58% | 58 |
|
|
2024
Q3 | $21.9M | Buy |
35,364
+302
| +0.9% | +$187K | 0.68% | 59 |
|
|
2024
Q2 | $19.4M | Buy |
35,062
+350
| +1% | +$194K | 0.64% | 58 |
|
|
2024
Q1 | $20.2M | Buy |
34,712
+3,294
| +10% | +$1.91M | 0.67% | 56 |
|
|
2023
Q4 | $16.7M | Sell |
31,418
-5,607
| -15% | -$2.98M | 0.58% | 57 |
|
|
2023
Q3 | $18.7M | Buy |
37,025
+396
| +1% | +$200K | 0.73% | 51 |
|
|
2023
Q2 | $19.1M | Buy |
36,629
+78
| +0.2% | +$40.7K | 0.71% | 53 |
|
|
2023
Q1 | $21.1M | Buy |
36,551
+2,833
| +8% | +$1.63M | 0.8% | 46 |
|
|
2022
Q4 | $18.6M | Buy |
+33,718
| New | +$18.6M | 0.74% | 46 |
|
|
2020
Q2 | – | Sell |
-2,408
| Closed | -$683K | – | 164 |
|
|
2020
Q1 | $683K | Buy |
2,408
+65
| +3% | +$18.4K | 0.04% | 112 |
|
|
2019
Q4 | $761K | Sell |
2,343
-50
| -2% | -$16.2K | 0.04% | 102 |
|
|
2019
Q3 | $697K | Buy |
2,393
+139
| +6% | +$40.5K | 0.04% | 98 |
|
|
2019
Q2 | $662K | Buy |
2,254
+56
| +3% | +$16.4K | 0.04% | 105 |
|
|
2019
Q1 | $602K | Hold |
2,198
| – | – | 0.03% | 110 |
|
|
2018
Q4 | $492K | Sell |
2,198
-17
| -0.8% | -$3.81K | 0.03% | 109 |
|
|
2018
Q3 | $541K | Buy |
2,215
+17
| +0.8% | +$4.15K | 0.03% | 116 |
|
|
2018
Q2 | $455K | Buy |
2,198
+1,991
| +962% | +$412K | 0.03% | 111 |
|
|
2018
Q1 | $43K | Buy |
+207
| New | +$43K | ﹤0.01% | 272 |
|